Compugen Ltd.
- CGEN
- NASDAQ
- Biotechnology
- Clinical-Stage Biotech
- Therapeutic Discovery
$1.98
Today +0.25%Quote Oct 20, 2026, 02:06 PM UTC
−20.88%over the last month
Max drawdown −21.3%From 1-month high −20.9%3 months −20.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Compugen
Compugen Ltd., an Israeli-based company established in 1993 and headquartered in Holon, is a clinical-stage enterprise focused on the discovery, development, and commercialization of therapeutic and product candidates. Its operations extend across Israel, the United States, and Europe.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
75
Market value
$187.1M
Quote Oct 20
Analyst target
$5.00
+153.2% from here
Floor
$1.97
0.4% below price
Resistance
$2.01
1.6% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about CGENPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free